Has Charles Smith received payments from drug or device companies?

Yes. Drug and device makers reported $540,995 in general payments to Charles Smith across 879 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Smith

Neurology · la Jolla, CANPI 1700959426

Payments from drug & device makers

$540,995in general payments, 2019–2025

Across 879 payments — averaging $615.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech, Inc.$167K
Biogen$113K
EMD Serono, Inc.$74K
Amgen$36K
Sanofi$31K
Genentech USA, Inc.$28K
plus $93K from 46 others

What the payments were for

Consulting fees$58,23317%
Speaking & faculty fees$243,06970%
Travel & lodging$27,3948%
Food & beverage$16,7845%
Education$4100%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech, Inc.	27	$167,317
Biogen	121	$112,720
EMD Serono, Inc.	116	$73,505
Amgen(2 entities)	84	$35,514
Sanofi	39	$31,002
Genentech USA, Inc.	36	$27,980
Bristol Myers Squibb	73	$27,327
F. Hoffmann-la Roche AG	7	$22,754
AstraZeneca	34	$17,243
E.r. Squibb & Sons, L.L.C.	13	$11,259
Novartis	113	$8,557
Johnson & Johnson	6	$1,975
AbbVie(2 entities)	71	$1,164
Upsher-smith Laboratories LLC	10	$229
Teva Pharmaceuticals USA, Inc.	10	$228
Adamas Pharmaceuticals, Inc.	11	$207
Sunovion Pharmaceuticals Inc.	13	$183
GE HealthCare	7	$174
Neurocrine Biosciences, Inc.	7	$163
Lilly USA, LLC	10	$158
Acadia Pharmaceuticals Inc	8	$128
Avanir Pharmaceuticals, Inc.	6	$116
Lundbeck LLC	4	$99
Otsuka America Pharmaceutical, Inc.	4	$88
Kyowa Kirin, Inc.	4	$84
Pfizer	5	$78
Acorda Therapeutics, Inc	4	$58
TG Therapeutics, Inc.	2	$47
Abbott	2	$44
Argenx US, Inc.	2	$43
Biohaven Pharmaceuticals, Inc.	2	$41
Ipsen Biopharmaceuticals, Inc	2	$40
Tanabe Pharma America, Inc.	2	$40
Mallinckrodt Enterprises LLC	2	$40
Banner Life Sciences, LLC	2	$39
Biohaven Pharmaceutical Holding Company Ltd.	1	$38
CSL Behring	2	$37
Saol Therapeutics Inc.	2	$32
Rochester Medical Corporation	2	$30
Promius Pharma LLC	1	$23
Grifols USA, LLC	1	$23
Merz North America, Inc.	1	$22
Mylan Specialty L.p.	1	$21
MDD US Operations, LLC	1	$20
Vertical Pharmaceuticals, LLC	1	$17
Supernus Pharmaceuticals, Inc.	1	$15
Alnylam Pharmaceuticals Inc.	1	$14
Assertio Therapeutics, Inc.	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	1	$13
Amneal Pharmaceuticals LLC	1	$13
Bayer	1	$13
Bausch Health US, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mavenclad$70,471
TYSABRI$54,772
UPLIZNA$34,009
OCREVUS$28,468
TECFIDERA$24,205
ZEPOSIA$22,036
Vumerity$21,995
AUBAGIO$21,334
Ozanimod$9,668
LEMTRADA$8,771
MAYZENT$5,320
SOLIRIS$4,967
Ponvory$375

How this compares

$540,995 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.

See all neurology providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dalfampridine ErDalfampridine	42	$23,330
Teriflunomide	12	$10,737
Methenamine Hippurate	26	$1,892
Baclofen	42	$1,624
Gabapentin	39	$1,571
Quetiapine Fumarate	11	$331
Primidone	18	$322
Amitriptyline Hcl	26	$225
Sumatriptan Succinate	19	$168
Levetiracetam	11	$83
Diazepam	12	$67

Paid to pharmacies, not to this prescriber.

Other neurology in la Jolla

John Ravitsla Jolla$8.4M
Jody Corey-Bloomla Jolla$2.3M
Douglas Galaskola Jolla$1.5M
Timothy CloughesyLos Angeles$33.1M
Jack FlorinFullerton$13M
David KudrowSanta Monica$12.8M
Perminder BhatiaFresno$8.3M
Perry ShiehLos Angeles$8.2M
Benjamin FrishbergCarlsbad$8.2M
Bruce CreeSan Francisco$8M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →